Female reproductive life span is extended by targeted removal of fibrotic collagen from the mouse ovary

Sci Adv. 2022 Jun 17;8(24):eabn4564. doi: 10.1126/sciadv.abn4564. Epub 2022 Jun 17.

Abstract

The female ovary contains a finite number of oocytes, and their release at ovulation becomes sporadic and disordered with aging and with obesity, leading to loss of fertility. Understanding the molecular defects underpinning this pathology is essential as age of childbearing and obesity rates increase globally. We identify that fibrosis within the ovarian stromal compartment is an underlying mechanism responsible for impaired oocyte release, which is initiated by mitochondrial dysfunction leading to diminished bioenergetics, oxidative damage, inflammation, and collagen deposition. Furthermore, antifibrosis drugs (pirfenidone and BGP-15) eliminate fibrotic collagen and restore ovulation in reproductively old and obese mice, in association with dampened M2 macrophage polarization and up-regulated MMP13 protease. This is the first evidence that ovarian fibrosis is reversible and indicates that drugs targeting mitochondrial metabolism may be a viable therapeutic strategy for women with metabolic disorders or advancing age to maintain ovarian function and extend fertility.

MeSH terms

  • Animals
  • Collagen / metabolism
  • Female
  • Fibrosis
  • Humans
  • Longevity*
  • Mice
  • Obesity / metabolism
  • Oocytes / metabolism
  • Ovary* / metabolism
  • Ovary* / pathology

Substances

  • Collagen